Search Test Directory


This interactive tool enables you to check if the test you need for your clinical trial can be performed by BARC global central laboratory.

Select your Department
Enter your Search Term (leave blank
to list all results in this department)


Our People

Peter Cole

Peter Cole

Dr. Peter Cole is the chairman of BARC SA , Managing Partner of Lancet laboratories , South Africa, a Director of Gaborone Private Hospital laboratory and a Director of the following lancet subsidiaries on the African continent :-

Ghana, Kenya, Mozambique, Nigeria, Swaziland, Tanzania, Uganda, Zambia, Zimbabwe.

Dr. Cole is also a former Director of the Clinix Hospital Group.
He is the current Chairman of the Tariff committee within the National Pathology Group. Dr. Cole qualified with an MBBCh from the University of the Witwatersrand in 1979. Thereafter he obtained the following qualifications from the S.A. College of medicine,

Dip. Mid. COG ; D CH and DA

He then completed a MMed. Path. (Chem) at the University of Cape Town.

In his Medical career Dr. Cole has served in the following positions, Medical Officer at Edendale hospital, SADF Medical Officer, Mine Medical Officer, Winkelhaak Mine, Pathology Registrar at the University of Cape Town and has been a Chemical Pathologist at Lancet laboratories since 1990.

Research and Publications:

Purine metabolism in red blood cells - Dissertation
Removal of hypoxanthine from ischaemic rat kidneys by PPRP-primed human erythrocytes - submitted to Transplantation


Marlene Kassel

Marlene Kassel

Marlene Kassel joined BARC SA in 2005 as Chief Operations Officer. Her wide spectrum of experience in the field of microbiology includes clinical trials management, research, training, human relations and staff management.

Mrs Kasssel previously worked for the National Health Laboratory Service (formerly the South African Institute for Medical Research) for 25 years as Chief Technologist before becoming Laboratory Manager of Infection Control Services.

Mrs Kassel has collaborated on articles published in the European Respiratory Journal, the Journal of Hospital Infection, the Southern African Journal of Epidemiology and Infection and the Journal of clinical Microbiology. Her poster presentations include Vancomycin Resistant Staphylococcus Aureus Occurs in South Africa and Glycopeptide Resistance in a Clinical Isolate of Bacillus Lentus in South Africa.


Peter Meewes

Peter Meewes

Peter Meewes joined BARC in 2005 as National Laboratory Manager South Africa.

As a microbiologist, he has spent more than 20 years working in clinical trials in Southern Africa. His experience includes heading up the Department of Serology and the incorporation of Endocrine and Allergies into the Serology Department for Dr CE Niehaus and work as a medical technologist and laboratory manager.

Mr Meewes has published widely, presented papers at conferences and attended international congresses including Allergology and Clinical Immunology in Australia and the HIV Vaccine Trials Network Conference in Washington.

Mr Meewes has extensive experience in PBMC processing and training as well as in setting up BARC’s world class Biobanking facility.


Carole

Carole Wallis

Carole Wallis is Head of the Specialty Molecular Division. She has a broad background in virology and molecular techniques, with specific training and expertise in HIV-1 drug resistance in subtype C and has carried out several studies looking at the development of drug resistance patterns in HIV-1 subtype C, the impact these mutations will have on newer antiretroviral compounds and the use of different diagnostic assays to detect these mutations.

She has supervised several post graduate degrees and is involved as a virologist on several large international studies.